BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36951580)

  • 1. Androgen therapy does not prevent bone loss and arterial calcifications in male rats with chronic kidney disease.
    David K; Dubois V; Verhulst A; Sommers V; Schollaert D; Deboel L; Moermans K; Carmeliet G; D'Haese P; Vanderschueren D; Claessens F; Evenepoel P; Decallonne B
    J Endocrinol; 2023 Jun; 257(3):. PubMed ID: 36951580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgens have antiresorptive effects on trabecular disuse osteopenia independent from muscle atrophy.
    Laurent MR; Jardí F; Dubois V; Schollaert D; Khalil R; Gielen E; Carmeliet G; Claessens F; Vanderschueren D
    Bone; 2016 Dec; 93():33-42. PubMed ID: 27622887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Sato H; Goto M; Nishimura G; Morimoto N; Tokushima H; Horii Y; Takahashi N
    Bone; 2023 Feb; 167():116613. PubMed ID: 36395959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency.
    Vanderschueren D; Van Herck E; Suiker AM; Visser WJ; Schot LP; Bouillon R
    Endocrinology; 1992 May; 130(5):2906-16. PubMed ID: 1572302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of GSK-3β increases trabecular bone volume but not cortical bone volume in adenine-induced uremic mice with severe hyperparathyroidism.
    Tatsumoto N; Arioka M; Yamada S; Takahashi-Yanaga F; Tokumoto M; Tsuruya K; Kitazono T; Sasaguri T
    Physiol Rep; 2016 Nov; 4(21):. PubMed ID: 27803315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model.
    Venken K; De Gendt K; Boonen S; Ophoff J; Bouillon R; Swinnen JV; Verhoeven G; Vanderschueren D
    J Bone Miner Res; 2006 Apr; 21(4):576-85. PubMed ID: 16598378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive protective effects of estrogen and androgen treatment on trabecular bone in ovariectomized rats.
    Tivesten A; Movérare-Skrtic S; Chagin A; Venken K; Salmon P; Vanderschueren D; Sävendahl L; Holmäng A; Ohlsson C
    J Bone Miner Res; 2004 Nov; 19(11):1833-9. PubMed ID: 15476584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of perinatal exposure to flutamide on sex hormone responsiveness in F1 male rats.
    Miyata K; Yabushita S; Sano M; Miyashita K; Okuno Y; Matsuo M
    J Toxicol Sci; 2003 Aug; 28(3):149-63. PubMed ID: 12974607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of androgen concentration on seminal vesicle blood flow in rats-establishment of new highly sensitive simultaneous androgen measurement method.
    Kashiwagi B; Shibata Y; Ono Y; Suzuki K; Honma S; Yamanaka H
    Urology; 2005 Jul; 66(1):218-23. PubMed ID: 15992887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of androgens, growth hormone, and IGF-I on bone and muscle in male mice during puberty.
    Venken K; Movérare-Skrtic S; Kopchick JJ; Coschigano KT; Ohlsson C; Boonen S; Bouillon R; Vanderschueren D
    J Bone Miner Res; 2007 Jan; 22(1):72-82. PubMed ID: 17014385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone Disorders and Male Hypogonadism in Kidney Disease.
    Garibotto G; Esposito P; Picciotto D; Verzola D
    Semin Nephrol; 2021 Mar; 41(2):114-125. PubMed ID: 34140090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
    George FW
    Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Neven E; Vervaet B; Brand K; Gottwald-Hostalek U; Opdebeeck B; De Maré A; Verhulst A; Lalau JD; Kamel S; De Broe ME; D'Haese PC
    Kidney Int; 2018 Jul; 94(1):102-113. PubMed ID: 29716795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenine-induced chronic kidney disease induces a similar skeletal phenotype in male and female C57BL/6 mice with more severe deficits in cortical bone properties of male mice.
    Metzger CE; Swallow EA; Stacy AJ; Allen MR
    PLoS One; 2021; 16(4):e0250438. PubMed ID: 33891630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.
    de Castro BBA; do Carmo WB; de Albuquerque Suassuna PG; Carminatti M; Brito JB; Dominguez WV; de Oliveira IB; Jorgetti V; Custodio MR; Sanders-Pinheiro H
    Exp Biol Med (Maywood); 2018 May; 243(9):796-802. PubMed ID: 29763365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
    Traish AM
    Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous BMP7 administration attenuated vascular calcification and improved bone disorders in chronic uremic rats.
    Lee CT; Kuo WH; Tain YL; Wang Y; Lee WC
    Biochem Biophys Res Commun; 2022 Sep; 621():8-13. PubMed ID: 35809346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 7α-methyl-19-nortestosterone vs. testosterone implants for hypogonadal osteoporosis: a preclinical study in the aged male orchidectomized rat model.
    Sinnesael M; Callewaert F; Morreels M; Kumar N; Sitruk-Ware R; Van Proeyen K; Hespel P; Boonen S; Claessens F; Vanderschueren D
    Int J Androl; 2011 Dec; 34(6 Pt 2):e601-11. PubMed ID: 21790658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potent synthetic androgens, dimethandrolone (7α,11β-dimethyl-19-nortestosterone) and 11β-methyl-19-nortestosterone, do not require 5α-reduction to exert their maximal androgenic effects.
    Attardi BJ; Hild SA; Koduri S; Pham T; Pessaint L; Engbring J; Till B; Gropp D; Semon A; Reel JR
    J Steroid Biochem Mol Biol; 2010 Oct; 122(4):212-8. PubMed ID: 20599615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.